Skip to main content

CORRECTION article

Front. Immunol., 27 July 2017
Sec. Cancer Immunity and Immunotherapy

Corrigendum: IL-1β, IL-8, and Matrix Metalloproteinases-1, -2, and -10 Are Enriched upon Monocyte–Breast Cancer Cell Cocultivation in a Matrigel-Based Three-Dimensional System

  • 1Unidad de Investigación en Virología y Cáncer, Hospital Infantil de México Federico Gómez, Ciudad de México, México
  • 2Programa de Doctorado en Ciencias Biomédicas, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México
  • 3Departamento de Patología, Hospital de Oncología, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México, México

A corrigendum on

IL-1β, IL-8, and Matrix Metalloproteinases-1, -2, and -10 Are Enriched upon Monocyte–Breast Cancer Cell Cocultivation in a Matrigel-Based Three-Dimensional System
by Espinoza-Sánchez NA, Chimal-Ramírez GK, Mantilla A, Fuentes-Pananá EM. Front Immunol (2017) 8:205. doi: 10.3389/fimmu.2017.00205

Corrigendum on: Figure 6 | Primary breast cancer (Brc) cells basal levels of secretion of inflammatory cytokines.

FIGURE 6
www.frontiersin.org

Figure 6. Primary breast cancer (BrC) cells basal levels of secretion of inflammatory cytokines. (A) The levels of the cytokines, chemokines, and growth factors of interest were determined in the supernatants of the 3D cultures of BrC primary isolates. Each point represents the mean of three determinations made for three independent cultures. The horizontal line represents the average of the primary cultures readings. (B) Comparison of the migratory properties of monocytes in response to GM-CSF, MCP-1, and RANTES. (C) Invasion assay with the commercial BrC cell lines in response to IL-8. Three independent experiments were performed. Statistical significance is indicated by ***p < 0.001 and **p < 0.01.

In the original article, there was a mistake in the Figure 6, panel B as published. The scale in the Y axes is incorrect. The corrected appears below: should be 20, 15, 10 and 5, instead of 200, 150, 100 and 50. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: breast cancer, monocytes, matrigel-based 3D culture, inflammation, IL-1β, IL-8, MMPs

Citation: Espinoza-Sánchez NA, Chimal-Ramírez GK, Mantilla A and Fuentes-Pananá EM (2017) Corrigendum: IL-1β, IL-8, and Matrix Metalloproteinases-1, -2, and -10 Are Enriched upon Monocyte–Breast Cancer Cell Cocultivation in a Matrigel-Based Three-Dimensional System. Front. Immunol. 8:856. doi: 10.3389/fimmu.2017.00856

Received: 28 June 2017; Accepted: 06 July 2017;
Published: 27 July 2017

Edited by:

Sherven Sharma, VA Greater Los Angeles Healthcare System (VHA), United States

Reviewed by:

Nejat K. Egilmez, University of Louisville, United States

Copyright: © 2017 Espinoza-Sánchez, Chimal-Ramírez, Mantilla and Fuentes-Pananá. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ezequiel Moisés Fuentes-Pananá, empanana@yahoo.com, ezequiel.fuentes@alumni.bcm.edu

These authors have contributed equally to this work.

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.